Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel

E Bequet1, H Sarter2,3, M Fumery4

  • 1Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Lille University Jeanne de Flandre Children's Hospital, University of Lille, Lille, France.

Insights

Very-early-onset inflammatory bowel disease (VEO-IBD) incidence remained stable, unlike early-onset IBD (EO-IBD) which increased. VEO-IBD presents differently, suggesting a genetic cause, while EO-IBD may be linked to environmental factors.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Epidemiology

Background:

  • Very-early-onset inflammatory bowel disease (VEO-IBD) is distinct from early-onset IBD (EO-IBD).
  • Comparing VEO-IBD (onset <6 years) and EO-IBD (onset 6-16 years) is crucial for understanding disease trajectories.
  • Longitudinal data analysis is needed to track incidence and phenotype changes over time.

Purpose of the Study:

  • To compare incidence trends and diagnostic phenotypes of VEO-IBD and EO-IBD.
  • To analyze changes in IBD presentation based on age at diagnosis.
  • To investigate potential etiological differences between VEO-IBD and EO-IBD.

Main Methods:

  • Utilized data from a prospective, population-based French registry (1988-2011).
  • Analyzed 1412 pediatric IBD cases, categorizing them into VEO-IBD (<6 years) and EO-IBD (6-16 years).
  • Compared incidence rates, clinical characteristics, and disease subtypes between the two groups.

Main Results:

  • VEO-IBD incidence was low and stable (3% of cases), while EO-IBD incidence significantly increased by 116% (p < 10-4).
  • VEO-IBD cases more frequently presented with ulcerative colitis or unclassified IBD (40% vs 26%, p=0.04) and symptoms like rectal bleeding.
  • Crohn's disease in VEO-IBD was more likely to involve isolated colonic disease (39% vs 14%, p=0.003).

Conclusions:

  • VEO-IBD incidence is stable with a distinct phenotype, suggesting a potential genetic etiology.
  • The rising incidence of EO-IBD may be associated with environmental factors.
  • Understanding these differences is key for targeted VEO-IBD and EO-IBD management.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
856
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
980
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K